SHAH GAURAV (See Remarks) sold 5.0% of their position (55.68K shares) of ROCKET PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $171.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/26/2026ACC: 0001140361-26-022894
DirectorOfficer· See Remarks
Since Jan 2019
-55.68K
Net shares
Net seller
$171.8K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
76.49K acquired · 132.17K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+76.49K
Price / share
$1.69
Trade value
$129.34K
% of position
7.3%
5/21/2026
1.04M→1.12M
Common Stock
Direct
Shares
−55.68K
Price / share
$3.09
Trade value
$171.84K
% of position
5.0%
5/21/2026
1.12M→1.06M
Total
Net shares
+20.81K
Net value
-$42.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/21/2026 | M · Option Exercise | +76.49K | $1.69 | $129.34K | 7.3% | 1.04M | 1.12M |
| Common Stock Direct | 5/21/2026 | S · Sale | −55.68K | $3.09 | $171.84K | 5.0% | 1.12M | 1.06M |
| Total | +20.81K | -$42.50K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
76.49K shares
Shares
−76.49K
Strike price
1.691
Held after
0.00
Exercisable
—
5/21/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock76.49K shares | 5/21/2026 | M · Option Exercise | −76.49K | 1.691 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned207.90K
Common Stock
IndirectShares owned198.34K
Total
406.24K indirect406.24K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 207.90K | Indirect |
| Common Stock | 198.34K | Indirect |
| Total | 406.24K | 406.24K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported